Hoffmann, K., Ganten, T. M., Gotthardt, D., Radeleff, B., Karapanagiotou-Schenkel, I., Kalle, C. v., . . . Schemmer, P. (2015). Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial. BMC cancer, 15, . https://doi.org/10.1186/s12885-015-1373-z
Chicago-Zitierstil (17. Ausg.)Hoffmann, Katrin, Tom M. Ganten, Daniel Gotthardt, Boris Radeleff, Irini Karapanagiotou-Schenkel, Christof von Kalle, Dirk Jäger, Markus W. Büchler, und Peter Schemmer. "Impact of Neo-adjuvant Sorafenib Treatment on Liver Transplantation in HCC Patients - a Prospective, Randomized, Double-blind, Phase III Trial." BMC Cancer 15 (2015). https://doi.org/10.1186/s12885-015-1373-z.
MLA-Zitierstil (9. Ausg.)Hoffmann, Katrin, et al. "Impact of Neo-adjuvant Sorafenib Treatment on Liver Transplantation in HCC Patients - a Prospective, Randomized, Double-blind, Phase III Trial." BMC Cancer, vol. 15, 2015, https://doi.org/10.1186/s12885-015-1373-z.